Search research articles
Contact Us
Filters
Showing results (1-10 of 28) with videos related to
Page
of 3
Sort By:
Blood Reviews
|
December 14, 2023
Optimizing high dose melphalan
Gunjan Shah, Sergio Giralt, Parastoo Dahi
Transplantation and Cellular Therapy
|
November 23, 2025
Incidence and Outcomes of Adenovirus Infections after Allogeneic Hematopoietic Cell Transplant with Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis
Maria Gianniki, Parastoo Dahi, Yeon Joo Lee, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 29, 2024
Influence of Obesity on the Efficacy and Toxicity of Patients Undergoing Autologous Hematopoietic Cell Transplantation for Lymphoma
Andrew Lin, Nicole Pearl, Jessica Flynn, et al.
Leukemia & Lymphoma
|
August 27, 2020
Modified SMILE (mSMILE) and intensity-modulated radiotherapy (IMRT) for extranodal NK-T lymphoma nasal type in a single-center population
Paola Ghione, Shunan Qi, Brandon S Imber, et al.
Transplantation and Cellular Therapy
|
May 24, 2021
Oral Proteasome Inhibitor Ixazomib for Switch-Maintenance Prophylaxis of Recurrent or Late Acute and Chronic Graft-versus-Host Disease after Day 100 in Allogeneic Stem Cell Transplantation
Natasia Rodriguez, Jasme Lee, Lisa Flynn, et al.
Clinical Pharmacokinetics
|
December 3, 2021
Population Pharmacokinetics of Melphalan in a Large Cohort of Autologous and Allogeneic Hematopoietic Cell Transplantation Recipients: Towards Individualized Dosing Regimens
Gunjan L Shah, Jaap Jan Boelens, Dean Carlow, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 17, 2020
Chimeric Antigen Receptor T Cell Therapy During the COVID-19 Pandemic
Veronika Bachanova, Michael R Bishop, Parastoo Dahi, et al.
Transplantation and Cellular Therapy
|
July 2, 2021
Fractionated Infusion of Hematopoietic Progenitor Cells Does Not Improve Neutrophil Recovery or Survival in Allograft Recipients
Roni Tamari, Samantha Brown, Sean M Devlin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 17, 2019
Ex Vivo T Cell-Depleted Hematopoietic Stem Cell Transplantation for Adult Patients with Acute Myelogenous Leukemia in First and Second Remission: Long-Term Disease-Free Survival with a Significantly Reduced Risk of Graft-versus-Host Disease
Juan Montoro, Izaskun Ceberio, Patrick Hilden, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 7, 2017
Prospective Evaluation of Unrelated Donor Cord Blood and Haploidentical Donor Access Reveals Graft Availability Varies by Patient Ancestry: Practical Implications for Donor Selection
Satyajit Kosuri, Tara Wolff, Sean M Devlin, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 28) with videos related to
Sort By:
Page
of 3
Blood Reviews
|
December 14, 2023
Optimizing high dose melphalan
Gunjan Shah, Sergio Giralt, Parastoo Dahi
Transplantation and Cellular Therapy
|
November 23, 2025
Incidence and Outcomes of Adenovirus Infections after Allogeneic Hematopoietic Cell Transplant with Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis
Maria Gianniki, Parastoo Dahi, Yeon Joo Lee, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 29, 2024
Influence of Obesity on the Efficacy and Toxicity of Patients Undergoing Autologous Hematopoietic Cell Transplantation for Lymphoma
Andrew Lin, Nicole Pearl, Jessica Flynn, et al.
Leukemia & Lymphoma
|
August 27, 2020
Modified SMILE (mSMILE) and intensity-modulated radiotherapy (IMRT) for extranodal NK-T lymphoma nasal type in a single-center population
Paola Ghione, Shunan Qi, Brandon S Imber, et al.
Transplantation and Cellular Therapy
|
May 24, 2021
Oral Proteasome Inhibitor Ixazomib for Switch-Maintenance Prophylaxis of Recurrent or Late Acute and Chronic Graft-versus-Host Disease after Day 100 in Allogeneic Stem Cell Transplantation
Natasia Rodriguez, Jasme Lee, Lisa Flynn, et al.
Clinical Pharmacokinetics
|
December 3, 2021
Population Pharmacokinetics of Melphalan in a Large Cohort of Autologous and Allogeneic Hematopoietic Cell Transplantation Recipients: Towards Individualized Dosing Regimens
Gunjan L Shah, Jaap Jan Boelens, Dean Carlow, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 17, 2020
Chimeric Antigen Receptor T Cell Therapy During the COVID-19 Pandemic
Veronika Bachanova, Michael R Bishop, Parastoo Dahi, et al.
Transplantation and Cellular Therapy
|
July 2, 2021
Fractionated Infusion of Hematopoietic Progenitor Cells Does Not Improve Neutrophil Recovery or Survival in Allograft Recipients
Roni Tamari, Samantha Brown, Sean M Devlin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 17, 2019
Ex Vivo T Cell-Depleted Hematopoietic Stem Cell Transplantation for Adult Patients with Acute Myelogenous Leukemia in First and Second Remission: Long-Term Disease-Free Survival with a Significantly Reduced Risk of Graft-versus-Host Disease
Juan Montoro, Izaskun Ceberio, Patrick Hilden, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 7, 2017
Prospective Evaluation of Unrelated Donor Cord Blood and Haploidentical Donor Access Reveals Graft Availability Varies by Patient Ancestry: Practical Implications for Donor Selection
Satyajit Kosuri, Tara Wolff, Sean M Devlin, et al.
Page
of 3